3 results
To investigate whether a treatment strategy offering bezlotoxumab before FMT in patients suffering from multiple recurrent CDI results in equal efficacy compared with a treatment strategy with initial FMT. Strategy A includes bezlotoxumab as…
Primary ObjectiveTo determine if an approach consisting of AV junction ablation and biventricular pacing is superior to optimal pharmacological rate control therapy in reducing total mortality at 48 months.Secondary ObjectiveTo determine if an…
The main goal is to achieve a means of communication solely based on brain signals for severely paralyzed patients. Success will constitute a significant advance in the field of BCI and of severe paralysis because it will be the first system that…